SpePharm Raises €26M to Spur Further Growth
SpePharm Holding BV closed on a €16 million (US$23.8 million) equity financing round to fund ongoing growth and entered into a €10 million revenue interest acquisition financing agreement related to its purchase of Dantrium for Europe and other markets from Procter & Gamble Pharmaceuticals, a division of P&G, of Cincinnati.
The special pharma company and JHP Pharmaceuticals LLC recently closed on their purchase of Dantrium (Dantrolene Sodium).
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST